Author

Maria Shirokova

Observed names: M. N. Shirokova, M. Shirokova, М.Н. Широкова

Institutions: Botkin Hospital, City Clinical Hospital

Observed institutions: Botkin Hospital, City Clinical Hospital, Volgograd Regional Clinical Oncology Center

ORCID: 0000-0002-5132-2996

Observed ORCID: 0000-0002-5132-2996

OpenAlex ID: A5029570553

Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias

2023 · Eugene Nikitin, Maria Kislova, et al. · Leukemia · 18

Pomalidomide in relapsed and refractory multiple myeloma: multicenter retrospective study

2022 · V. G. Potapenko, E. V. Baumert, et al. · Oncohematology · 2

Pb2021: Quality of Life and Clinical Outcomes in Patients With Relapsed/refractory Multiple Myeloma (rrmm) Treated With Ixazomib-lenalidomide-dexamethasone (ird): Results of a Real-world Evidence Study

2022 · T. Ionova, O. Vinogradova, et al. · HemaSphere · 1

Programmed Treatment of HIV-Associated Burkitt Lymphoma in Patients with Low Physical Status

2020 · К.Д. Капланов, Н.В. Коваленко, et al. · Гематология Трансфузиология Восточная Европа

Works count: 4

Citation count: 21

H-index: 2

I10-index: 1